L2 Asset Management LLC Has $1.13 Million Stock Holdings in Chemed Corporation $CHE

L2 Asset Management LLC lifted its stake in Chemed Corporation (NYSE:CHE) by 85.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 2,651 shares of the company’s stock after acquiring an additional 1,225 shares during the quarter. L2 Asset Management LLC’s holdings in Chemed were worth $1,134,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also modified their holdings of the company. Los Angeles Capital Management LLC acquired a new position in shares of Chemed in the fourth quarter worth $26,000. Smartleaf Asset Management LLC increased its stake in shares of Chemed by 71.4% in the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock worth $27,000 after acquiring an additional 25 shares during the last quarter. BOK Financial Private Wealth Inc. acquired a new position in shares of Chemed in the fourth quarter worth $27,000. Global Retirement Partners LLC increased its stake in shares of Chemed by 200.0% in the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock worth $37,000 after acquiring an additional 58 shares during the last quarter. Finally, Geneos Wealth Management Inc. increased its stake in shares of Chemed by 330.4% in the first quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock worth $61,000 after acquiring an additional 76 shares during the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Chemed Stock Up 2.2%

CHE stock opened at $432.70 on Wednesday. The company has a debt-to-equity ratio of 0.11, a current ratio of 0.85 and a quick ratio of 0.83. Chemed Corporation has a 52-week low of $365.20 and a 52-week high of $562.77. The company has a 50-day moving average of $417.17 and a two-hundred day moving average of $424.24. The stock has a market capitalization of $5.74 billion, a price-to-earnings ratio of 23.58, a price-to-earnings-growth ratio of 1.59 and a beta of 0.54.

Chemed (NYSE:CHE) last released its quarterly earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The company had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. During the same period in the prior year, the company earned $5.63 earnings per share. The business’s quarterly revenue was up 1.6% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. As a group, equities research analysts anticipate that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were issued a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date was Thursday, May 28th. Chemed’s dividend payout ratio is 13.08%.

Insider Transactions at Chemed

In other Chemed news, Director Andrea R. Lindell sold 1,347 shares of the company’s stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director directly owned 4,578 shares in the company, valued at $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $421.13, for a total transaction of $842,260.00. Following the sale, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 3.33% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on CHE shares. Zacks Research upgraded shares of Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Oppenheimer decreased their price objective on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, February 27th. Weiss Ratings upgraded shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Wall Street Zen cut shares of Chemed from a “buy” rating to a “hold” rating in a report on Monday, June 8th. Finally, Royal Bank Of Canada upped their price objective on shares of Chemed from $422.00 to $436.00 and gave the stock a “sector perform” rating in a report on Monday, April 27th. Two analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to data from MarketBeat.com, Chemed presently has a consensus rating of “Hold” and an average target price of $501.50.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.